Frailty Rehabilitation for Older Adults with Frailty
Trial Summary
What is the purpose of this trial?
Frailty is an important clinical state that contributes to falls, hospitalization, institutionalization and death. When an individual simultaneously has many health problems, a frailty "tipping point" may be triggered by even a minor stressful event such as adding a new drug or urinary tract infection. Our research suggests that approximately 23% of Canadians over age 65 are frail, and by age 85 this estimate increases to over 40%. As we learn more about frailty and its consequences, there is an urgent need to develop community-based interventions that will prevent or delay frailty in older adults. Our proposed study will examine if frailty rehabilitation program is an effective community-based intervention to promote healthy aging. The primary objective of our study is to determine if 4-month frailty rehabilitation improves physical function compared with control and exercise alone in community-dwelling older adults living with frailty and sarcopenia. Secondary objectives of our study are to determine if 4-months of frailty rehabilitation can improve functional abilities and reduce healthcare utilization during a 6-month follow-up period compared with control and exercise alone. Results will translate the first Canadian model of frailty and sarcopenia rehabilitation and management.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are currently in a drug optimization study or program, you would not be eligible to participate.
What data supports the effectiveness of the treatment for frailty rehabilitation in older adults?
Research shows that group exercise programs like the Otago exercise program can significantly reduce frailty in older adults, and the Walk With Ease program has been effective in achieving exercise goals and satisfaction among participants. Additionally, social activities and community engagement have been linked to improvements in frailty, suggesting that combining physical and social interventions can be beneficial.12345
Is the frailty rehabilitation program safe for older adults?
The frailty rehabilitation programs, including high-intensity walking and exercise combined with nutrition education, have been shown to be safe for older adults, with no reported adverse events in the studies. Participants found these programs satisfactory and beneficial for improving physical function.46789
How is the 'Walk With Ease Program' treatment different from other treatments for frailty in older adults?
The 'Walk With Ease Program' is unique because it combines group exercise with social interaction and community engagement, which has been found to be more effective than home-based exercise for improving frailty. This approach not only focuses on physical activity but also emphasizes socialization, which can enhance motivation and adherence to the program.1011121314
Research Team
Alexandra Papaioannou, MD, MSc
Principal Investigator
McMaster University
Eligibility Criteria
This trial is for community-dwelling adults over 65 who can walk 25m with/without aid, have medical clearance, and can get to the YMCA twice a week. They must be fully vaccinated against COVID-19 and at high risk for mobility issues but not in palliative care or other specific health programs.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 4-month frailty rehabilitation program, including group exercise, supplemental home exercise, nutrition, protein supplementation, and medication review.
Follow-up
Participants are monitored for functional abilities and healthcare utilization during a 6-month follow-up period.
Treatment Details
Interventions
- Control (Other)
- Group Exercise (Behavioural Intervention)
- Socialization (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor
Evan Stein
McMaster University
Chief Medical Officer since 2015
MD, PhD
Sam
McMaster University
Chief Executive Officer since 2023
MBA from McMaster University